The best place for the Latest Cardiac and Vascular News
UPPSALA, Sweden, Dec. 02, 2021 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that its project with Boehringer Ingelheim, assessing the potential utility of protein biomarkers in the empagliflozin EMPEROR studies, recently entered the data analysis phase. Empagliflozin, approved in the US under the tradename JARDIANCE, […]
Gold Coast, Queensland, Australia, Dec. 02, 2021 (GLOBE NEWSWIRE) — Cholrem (Australia) Pty Ltd have produced a product CAVADEX (Beta-Cyclodextrin) which reverses heart disease by removing cholesterol from damaged and narrowed arteries after only a few months, resulting in reduced arterial plaque. Atherosclerosis, also known as heart disease, is the […]
Results previously presented in a Late-Breaking Science Session at the American Heart Association’s 2021 Scientific Sessions Global Phase 3 trial of bentracimab achieved both primary reversal endpoint and co-primary endpoint of clinical hemostasis Bentracimab had no drug-related serious adverse events MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)–PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a […]
Acquisition expands Integer’s cardiovascular and neurostimulation product portfolio through broadened product offering and addition of low-cost manufacturing capacity PLANO, Texas, Dec. 02, 2021 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer today announced the close of its acquisition of Oscor, Inc., a privately-held […]
UPPSALA, Sweden, Dec. 02, 2021 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that its project with Boehringer Ingelheim, assessing the potential utility of protein biomarkers in the empagliflozin EMPEROR studies, recently entered the data analysis phase. Empagliflozin, approved in the US under the tradename JARDIANCE, […]
SOUTH SAN FRANCISCO, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on November 30, 2021 it granted stock options to purchase an aggregate of 143,500 shares of common stock to 9 new employees, whose employment commenced in November 2021, as a material inducement to […]
Gold Coast, Queensland, Australia, Dec. 02, 2021 (GLOBE NEWSWIRE) — Cholrem (Australia) Pty Ltd have produced a product CAVADEX (Beta-Cyclodextrin) which reverses heart disease by removing cholesterol from damaged and narrowed arteries after only a few months, resulting in reduced arterial plaque. Atherosclerosis, also known as heart disease, is the […]
Former Medtronic Executive Brings Significant Experience in Cardiac and Remote Patient Monitoring to Help Deliver Qardio’s Mission to Transform Cardiac and Chronic Care AMSTERDAM & SAN FRANCISCO–(BUSINESS WIRE)–Qardio, Inc. (“Qardio” or “Company”), a medical technology company that operates at the intersection of cardiology and remote patient monitoring, today announced the Company’s […]
Clinical, science, and natural products industry experts to advance Company’s research, clinical studies, and product development strategies SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Calroy Health Sciences, a company dedicated to developing innovative natural solutions to optimize cardiovascular health, today announced the establishment of a science and medical advisory board comprised of leading researchers and […]
Results previously presented in a Late-Breaking Science Session at the American Heart Association’s 2021 Scientific Sessions Global Phase 3 trial of bentracimab achieved both primary reversal endpoint and co-primary endpoint of clinical hemostasis Bentracimab had no drug-related serious adverse events MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)–PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a […]
Seasoned electrophysiology sales executive joins the Company to expand the commercial footprint of its signal processing technology for arrhythmia care Westport, CT, Dec. 01, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve […]
The INSIGHT international, multicenter, randomized, placebo-controlled pivotal Phase II/III clinical study will be conducted with a 3.7 g/day dose of TOTUM•854 on 400 volunteers; The INSIGHT 2 international, multicenter, randomized, placebo-controlled Phase II/III clinical study will be conducted with a 2.6 g/day dose of TOTUM•854 on 400 volunteers; The clinical […]
Commence a strategic partnership to advance women’s heart and brain health through awareness and prevention TORONTO–(BUSINESS WIRE)–Munich Reinsurance Company’s Canadian life branch (Munich Re) today announced a strategic partnership with Heart & Stroke reinforcing its commitment to combatting cardiovascular disease. With this partnership, Munich Re will provide financial support for […]
